These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18821746)

  • 21. Development of a Ligand Screening Tool Using Full-Length Human Peroxisome Proliferator-Activated Receptor-Expressing Cell Lines to Ameliorate Metabolic Syndrome.
    Tachibana K; Ishimoto K; Takahashi R; Kadono H; Awaji T; Yuzuriha T; Tanaka T; Hamakubo T; Sakai J; Kodama T; Aoki S; Doi T
    Chem Pharm Bull (Tokyo); 2019; 67(3):199-202. PubMed ID: 30827999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.
    Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H
    J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors.
    Miyachi H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity.
    Motoshima K; Ishikawa M; Hashimoto Y; Sugita K
    Bioorg Med Chem; 2011 May; 19(10):3156-72. PubMed ID: 21514830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of dimeric PPAR agonists.
    Sauerberg P; Mogensen JP; Jeppesen L; Svensson LA; Fleckner J; Nehlin J; Wulff EM; Pettersson I
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1497-500. PubMed ID: 15713415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development.
    Hong F; Xu P; Zhai Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.
    Pirard B
    J Comput Aided Mol Des; 2003 Nov; 17(11):785-96. PubMed ID: 15072437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
    Hummasti S; Tontonoz P
    Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
    Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P
    Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor ligands in atherosclerosis.
    Viles-Gonzalez JF; Choi BG; Fuster V; Badimon JJ
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1393-403. PubMed ID: 15500388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
    Maltarollo VG; Togashi M; Nascimento AS; Honorio KM
    PLoS One; 2015; 10(3):e0118790. PubMed ID: 25767888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F; Jaber LA; Berlie HD; O'Connell MB
    Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
    Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for physiologically relevant peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands.
    Subramani PA; Reddy MC; Narala VR
    Endocr Metab Immune Disord Drug Targets; 2013 Jun; 13(2):175-83. PubMed ID: 23713695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.